

LONDON (Alliance News) - Oxford Biomedica PLC said Monday it had completed patient recruitment for its Phase I trial of neovascular wet age-related ma...


Shares in Oxford Biomedica rise as much as 14 percent as the company-funded study on Parkinson's disease treatment yields promising results and shows ...


Shares in Oxford BioMedica jumped after French and US regulators gave their approval for the biopharmaceutical group to resume recruitment for trials ...